FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

US Specialty Formulations B-Complex + Chromic Chloride Recall

B-Complex + Chromic Chloride (Choline Chloride 3%, Inositol 3%, Pyridoxine HCl 2%, Niac…

US Specialty Formulations LLC · Allentown, PA

Risk level
Class II
Reported by FDA
Jun 15, 2022
Recall ID
D-0987-2022
Check your lot numberHow we source this data

Summary

US Specialty Formulations recalled B-Complex + Chromic Chloride starting May 24, 2022. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0987-2022 on Jun 15, 2022. Reason: Lack of Assurance of Sterility. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility

Product description

B-Complex + Chromic Chloride (Choline Chloride 3%, Inositol 3%, Pyridoxine HCl 2%, Niacinamide 2%, Thiamine HCl 2%, Chlorobutanol 0.5%, Riboflavin 0.05%, Chromic Chloride 0.003%), 30 mL Multi-Dose Vial, packaged in 2 x 30 mL Multi-Dose Vials per carton, US Specialty Formulations, LLC, 116 Research Drive, Bethlehem, PA 18015, P/N: 234-15523

Lot numbers, UPCs & expiration codes

Lot #: 02RP1507A, exp. date 30-Jun-22; 02RP1512A, exp. date 30-Sep-22; 02RP1514A, exp. date 31-Nov-22; 02RP1515A, exp. date 31-Dec-22

Where it was sold

Product was distributed to medical facilities and a physician's office Nationwide in the USA.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0987-2022
Classification
Class II
Status
Terminated
Recall initiated
May 24, 2022
FDA report date
Jun 15, 2022
Quantity
1992 vials
Recall type
Voluntary: Firm initiated
Recalling firm
US Specialty Formulations LLC

Original FDA data

Every field from FDA enforcement report D-0987-2022, exactly as published.

Show all FDA fields
City
Allentown
State
PA
Status
Terminated
Country
United States
Event ID
90257
Address
1401 S Albert St
Code information
Lot #: 02RP1507A, exp. date 30-Jun-22; 02RP1512A, exp. date 30-Sep-22; 02RP1514A, exp. date 31-Nov-22; 02RP1515A, exp. date 31-Dec-22
Postal code
18103-4141
Report date
Jun 15, 2022
Product type
Drugs
Recall number
D-0987-2022
Classification
Class II
Recalling firm
US Specialty Formulations LLC
Product quantity
1992 vials
Termination date
Jun 17, 2024
Reason for recall
Lack of Assurance of Sterility
Voluntary / mandated
Voluntary: Firm initiated
Product description
B-Complex + Chromic Chloride (Choline Chloride 3%, Inositol 3%, Pyridoxine HCl 2%, Niacinamide 2%, Thiamine HCl 2%, Chlorobutanol 0.5%, Riboflavin 0.05%, Chromic Chloride 0.003%), 30 mL Multi-Dose Vial, packaged in 2 x 30 mL Multi-Dose Vials per carton, US Specialty Formulations, LLC, 116 Research Drive, Bethlehem, PA 18015, P/N: 234-15523
Distribution pattern
Product was distributed to medical facilities and a physician's office Nationwide in the USA.
Recall initiation date
May 24, 2022
Initial firm notification
Letter
Center classification date
Jun 6, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0987-2022, published Jun 15, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls